We Operate Exclusive High-Performance
International Clinical Trial Investigative Sites
CLINICAL TRIAL INVESTIGATIVE SITES
DELTA HEALTH collaborates with partner companies and healthcare organizations for managing clinical trial investigative sites based on the maxim.....EXPERIENCE.....INTEGRITY....QUALITY.
We have long-term exclusivity agreements with globally located prominent teaching hospitals and clinics to operate state-of-the-art clinical investigative sites having extensive experience in conducting drug development clinical trials according to GCP-ICH standards.
A number of these high-performance international investigative sites, covering a multi-ethnic catchment area population of 10 million plus, have preferred access to a fast growing, highly compliant local clinical trial subject populace.
The North American audited and qualified international investigative sites, primarily focused on conducting Phase 1, Phase 2 and Phase 3 clinical trials, are directly managed by the DELTA HEALTH team members who have in-depth knowledge and hands-on experience in clinical trial site management. These DELTA specialists have also been involved with multiple global drug development clinical programs that have resulted in successful regulatory approvals from the United States FDA and Health Canada.